Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Apr 15;147(24):1788–1797. doi: 10.1161/CIRCULATIONAHA.123.064361

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 The Authors.

Circulation is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.

PMC Copyright notice

Figure 4. — Cumulative incidences of AF diagnosis according to NT-proBNP subgroups. The absolute risk of atrial fibrillation (AF) diagnosis in the control and implantable loop recorder (ILR) groups according to NT-proBNP (N-terminal pro-B-type natriuretic peptide) subgroups. Cumulative incidences were plotted with the Aalen-Johansen estimator with death as competing risk. Hazard ratios (HRs) with 95% CI and P values were determined in cause-specific Cox models adjusted for sex, age, body mass index, weekly alcohol consumption, smoking pack-years, estimated glomerular filtration rate, total cholesterol concentration, hypertension, diabetes, previous stroke, heart failure, valvular heart disease, ischemic heart disease, and peripheral artery disease. The conversion factor for NT-proBNP expressed as pg/mL is 1 pg/mL=0.12 pmol/L. Hence, 15 pmol/L corresponds to 125 pg/mL.